Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sara Kathryn Smith"'
Publikováno v:
Vaccines, Vol 12, Iss 4, p 376 (2024)
Measles, mumps, rubella (MMR), and varicella incidence rates have increased due to the delayed vaccination schedules of children secondary to the COVID-19 pandemic. Decreased herd immunity creates a risk for immunocompetent children and immunocomprom
Externí odkaz:
https://doaj.org/article/cb7910f8388a4ba48dee289584812c87
Autor:
Sara Kathryn Smith, Tamir Miloh
Publikováno v:
Clinics in liver disease. 26(3)
Liver transplantation (LT) for children results in excellent short- and long-term patient and graft survival. LT is a lifesaving procedure in children with acute or chronic liver disease, hepatic tumors, and select genetic metabolic diseases in which
Autor:
Sara Kathryn Smith, Philip Rosenthal
Publikováno v:
F1000Research, Vol 6 (2017)
Although there have been advances made in the diagnosis and management of pediatric acute liver failure, there is still no consensus regarding the definition or standardized evaluation, and an inability to predict outcomes, specifically irreversible
Externí odkaz:
https://doaj.org/article/541f006034fa4dbd8194a7879b3f89a5
Autor:
Sara Kathryn Smith
Publikováno v:
Advances in Pediatrics. 67:47-56
Autor:
Sara Kathryn Smith, Emily R. Perito
Publikováno v:
Clinics in Liver Disease. 22:723-733
Pediatric nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children. The spectrum of NAFLD ranges from steatosis to nonalcoholic steatohepatitis (NASH) to fibrosis. Obesity rates in children continue to rise and,
Publikováno v:
Liver Disease in Children
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c8e71339906c51935a1615a48a4be45
https://doi.org/10.1017/9781108918978.017
https://doi.org/10.1017/9781108918978.017
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 63:516-517
Currently the only Food and Drug Administration-approved treatment for children with chronic hepatitis C virus is pegylated interferon with ribavirin, which is associated with significant adverse effects and low sustained virologic response rates. In
Publikováno v:
Vaccines; Apr2024, Vol. 12 Issue 4, p376, 10p
Publikováno v:
Vaccine Weekly; 4/19/2024, p957-957, 1p